Alvotech (ALVOW)
ALVOW Stock Price Chart
Explore Alvotech interactive price chart. Choose custom timeframes to analyze ALVOW price movements and trends.
ALVOW Company Profile
Discover essential business fundamentals and corporate details for Alvotech (ALVOW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
16 Jun 2022
Employees
1.01k
Website
https://www.alvotech.comCEO
Lisa Graver
Description
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
ALVOW Financial Timeline
Browse a chronological timeline of Alvotech corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Aug 2026
EPS estimate is -$0.04, while revenue estimate is $111.50m.
Earnings released on 6 May 2026
EPS came in at -$0.09 falling short of the estimated -$0.05 by -91.49%, while revenue for the quarter reached $105.90m , missing expectations by -5.77%.
Earnings released on 18 Mar 2026
EPS came in at $0.01 surpassing the estimated -$0.01 by +239.83%, while revenue for the quarter reached $173.20m , beating expectations by +6.79%.
Earnings released on 12 Nov 2025
EPS came in at -$0.02 surpassing the estimated -$0.03 by +34.71%, while revenue for the quarter reached $113.95m , missing expectations by -2.04%.
Earnings released on 13 Aug 2025
EPS came in at $0.11 surpassing the estimated -$0.05 by +330.17%, while revenue for the quarter reached $173.24m , beating expectations by +47.64%.
ALVOW Stock Performance
Access detailed ALVOW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
